immune checkpoint inhibitors
Study Assesses Immune-Related AEs in Genitourinary Cancer Patients
Gastrointestinal immune-related adverse events (irAEs) are the most common AEs that lead to hospital admissions and ...
MAY 28, 2025
New Study Finds Potential Treatment Strategies for Immunotherapy-Associated Myocarditis
Immune checkpoint inhibitors have saved the lives of countless patients across a variety of cancers, but the ...
DECEMBER 23, 2022
Immune-Related AEs Predict Positive Outcomes in NSCLC
Immune-related adverse events during therapy with a checkpoint inhibitor predict positive treatment outcomes in ...
SEPTEMBER 13, 2021
Predicting Outcomes With Checkpoint Inhibitors in Colorectal Cancer
A cytolytic activity score (CYT), designed to quantify the amount of killing activity of immune cells against ...
SEPTEMBER 24, 2018
Immune Checkpoint Inhibitors in SCLC
Antibodies targeting immune checkpoint inhibitors may be effective in improving survival outcome in patients with ...
JULY 29, 2016